Stock Fundamentals

Company Information

Company Name
ReWalk Robotics Ltd
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: IL0011331076
CIK: 0001607962
CUSIP:
Currency: USD
Full Time Employees: 81
Phone: 972 4 959 0123
Fiscal Year End: December
IPO Date: Sep 12, 2014
Description:

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Address:

3 Hatnufa St., Yokneam Illit, Israel, 2069203

Directors & Officers

Name Title Year Born
Mr. William Mark Grant President, CEO & Director 1971
Mr. Almog Adar Chief Financial Officer 1985
Ms. Jeannine Lynch Vice President of Market Access & Strategy 1966
Ms. Miri Pariente Vice President of Operations, Regulatory & Quality 1977
Ms. Judy Kula Vice President of Customer Service, Human Resources & Business Affairs NA
Dr. Keith Dale Rose M.D. Chief Medical Officer NA
Mr. Craig Peters DPT Vice President of Sales - North America NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Sep 02, 2025 Jeannine Lynch N/A Sale 132.00 $7.68 $1.01K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Renaissance Technologies Corp 11.43K Mar 31, 2026 0.41% $0.00 5.73%
UBS Group AG 2.13K Mar 31, 2026 0.08% $0.00 33.65%
Morgan Stanley - Brokerage Accounts 208.00 Mar 31, 2026 0.01% $0.00 0.00%
SBI Securities Co Ltd 196.00 Mar 31, 2026 0.01% $0.00 2.62%
Advisor Group Holdings, Inc. 107.00 Mar 31, 2026 0.00% $0.00 311.54%
Motiv8 Investments LLC 41.00 Dec 31, 2025 0.00% $0.00 0.00%
NATIONAL BANK OF CANADA /FI/ 11.00 Mar 31, 2026 0.00% $0.00 -8.33%
Royal Bank of Canada 5.00 Dec 31, 2025 0.00% $0.00 25.00%
Susquehanna International Group, LLP 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Jane Street Group LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Wells Fargo & Co 0.00 Mar 31, 2026 0.00% $0.00 0.00%
HighTower Advisors, LLC 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
SIMPLEX TRADING, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Robertson Stephens Wealth Management, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Citigroup Inc 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
Citadel Advisors Llc 0.00 Dec 31, 2025 0.00% $0.00 -100.00%
GSA Capital Partners LLP 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
LPL Financial Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
XTX Topco Ltd 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
TWO SIGMA SECURITIES, LLC 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 2.81M
Shares Float: 1.55M
% Insiders: 4,760.20%
% Institutions: 78.80%
Short % Float: 4.84%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 216.00 0.01% ▲ 0.00% Mar 31, 2026

Valuation Metrics

Enterprise Value: $19.77M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $20.49M
EBITDA: $-17.18M
Book Value: $5.52
Earnings/Share: $-18.33
Profit Margin: -123.66%
Operating Margin: -123.35%
ROA (TTM): -35.12%
ROE (TTM): -209.10%
Revenue (TTM): $20.92M
Revenue/Share (TTM): $15.56
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -22.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.31x 0.05x 0.63x -57.26x -0.03x
2024-12-31 2.08x 0.05x 0.38x -152.76x -0.03x
2023-12-31 3.33x 0.03x 0.26x -1,180.60x -0.06x
2023-09-30 3.33x 0.03x 0.26x N/A N/A
2022-12-31 15.16x 0.01x 0.08x -868.27x -0.03x
2022-09-30 15.16x 0.01x 0.08x N/A N/A
2021-12-31 22.91x 0.01x 0.06x -506.20x -0.05x
2021-09-30 22.91x 0.01x 0.06x N/A N/A
2020-12-31 5.41x 0.03x 0.22x -12.91x -0.06x
2020-09-30 5.41x 0.03x 0.22x N/A N/A
2019-12-31 2.07x 0.71x 0.56x -9.18x -0.55x
2018-12-31 2.46x 0.89x 0.87x -7.93x -0.09x
2017-12-31 2.15x 1.74x 0.84x -8.86x -0.30x
2016-12-31 2.38x 0.91x 0.74x -15.14x -0.25x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LFWD.US!